Increased levels of 3-hydroxykynurenine in different brain regions of rats with chronic renal insufficiency

被引:34
作者
Topczewska-Bruns, J [1 ]
Pawlak, D [1 ]
Chabielska, E [1 ]
Tankiewicz, A [1 ]
Buczko, W [1 ]
机构
[1] Med Acad Bialystok, Dept Pharmacodynam, PL-15230 Bialystok, Poland
关键词
tryptophan; kynurenine; uremia; rat; central nervous system;
D O I
10.1016/S0361-9230(02)00813-4
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Tryptophan (TRIP) metabolism via the kynurenine pathway leads to formations of neuroactive substances like kynurenine (KYN) and 3-hydroxykynurenine (3-HK), which may be involved in the pathogenesis of several human brain diseases. 3-Hydroxykynurenine especially is known to have strong neurotoxic properties. The generation of reactive oxygen species (ROS) leads to neuronal cell death with apoptotic features. Because the chronic renal insufficiency (CRI) results in disturbances in the functioning of the central nervous system (CNS), it is conceivable that the metabolism of some kynurenines may be altered and could play an important role in uremic encephalophaty. The levels of TRIP, KYN and 3-HK were measured in the plasma and in different brain regions of uremic rats. The total plasma concentration of TRP as well as in all the studied brain samples was significantly diminished during uremia. Surprisingly, the level of KYN and 3-HK were elevated both in the plasma and different brain regions of CRI animals. KYN concentrations were approximately two times higher in the cerebellum, midbrain and cortex compared to the control group. The changes of 3-HK levels were more pronounced in the striatum and medulla than in other structures. This data suggests that CRI results in deep disturbances on the kynurenine pathway in CNS, which could be responsible for neurological abnormalities seen in uremia. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:423 / 428
页数:6
相关论文
共 41 条
[1]
Aguilera A, 2000, PERITON DIALYSIS INT, V20, P810
[2]
BIOCHEMISTRY OF TRYPTOPHAN IN HEALTH AND DISEASE [J].
BENDER, DA .
MOLECULAR ASPECTS OF MEDICINE, 1983, 6 (02) :101-197
[3]
BERGQVIST PBF, 1995, J NEUROCHEM, V65, P2235
[4]
Neurology and the kidney [J].
Burn, DJ ;
Bates, D .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 65 (06) :810-821
[5]
OXIDATIVE STRESS, GLUTAMATE, AND NEURODEGENERATIVE DISORDERS [J].
COYLE, JT ;
PUTTFARCKEN, P .
SCIENCE, 1993, 262 (5134) :689-695
[6]
BEHAVIORAL TOXICITY OF GUANIDINOSUCCINIC ACID IN ADULT AND YOUNG MICE [J].
DHOOGE, R ;
PEI, YQ ;
MARESCAU, B ;
DEDEYN, PP .
TOXICOLOGY LETTERS, 1992, 64-5 :773-777
[7]
UPTAKE OF 3-HYDROXYKYNURENINE MEASURED IN RAT-BRAIN SLICES AND IN A NEURONAL CELL-LINE [J].
EASTMAN, CL ;
GUILARTE, TR ;
LEVER, JR .
BRAIN RESEARCH, 1992, 584 (1-2) :110-116
[8]
BLOOD-BRAIN-BARRIER TRANSPORT OF KYNURENINES - IMPLICATIONS FOR BRAIN SYNTHESIS AND METABOLISM [J].
FUKUI, S ;
SCHWARCZ, R ;
RAPOPORT, SI ;
TAKADA, Y ;
SMITH, QR .
JOURNAL OF NEUROCHEMISTRY, 1991, 56 (06) :2007-2017
[9]
L-KYNURENINE - ITS SYNTHESIS AND POSSIBLE REGULATORY FUNCTION IN BRAIN [J].
GAL, EM ;
SHERMAN, AD .
NEUROCHEMICAL RESEARCH, 1980, 5 (03) :223-239
[10]
GILES AR, 1987, THROMB HAEMOSTASIS, V58, P1078